Artemether-Lumefantrine Versus Chloroquine for the Treatment of Uncomplicated Plasmodium knowlesi Malaria: An Open-Label Randomized Controlled Trial CAN KNOW

BACKGROUND: Plasmodium knowlesi is reported increasingly across Southeast Asia and is the most common cause of malaria in Malaysia. No randomized trials have assessed the comparative efficacy of artemether-lumefantrine (AL) for knowlesi malaria. METHODS: A randomized controlled trial was conducted i...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Infect Dis
Главные авторы: Grigg, Matthew J, William, Timothy, Barber, Bridget E, Rajahram, Giri S, Menon, Jayaram, Schimann, Emma, Wilkes, Christopher S, Patel, Kaajal, Chandna, Arjun, Price, Ric N, Yeo, Tsin W, Anstey, Nicholas M
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2018
Предметы:
Articles and Commentaries
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5790171/
https://ncbi.nlm.nih.gov/pubmed/29020373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix779
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы